Format
Sort by
Items per page

Send to

Choose Destination

Best matches for cost benefit AND cost effectiveness AND knee replacement arthroplasty (procedure):

Search results

Items: 1 to 20 of 238

1.

Impact of total knee replacement practice: cost effectiveness analysis of data from the Osteoarthritis Initiative.

Ferket BS, Feldman Z, Zhou J, Oei EH, Bierma-Zeinstra SM, Mazumdar M.

BMJ. 2017 Mar 28;356:j1131. doi: 10.1136/bmj.j1131.

2.

Effect of Tranexamic Acid on Transfusion Rates Following Total Joint Arthroplasty: A Cost and Comparative Effectiveness Analysis.

Evangelista PJ, Aversano MW, Koli E, Hutzler L, Inneh I, Bosco J, Iorio R.

Orthop Clin North Am. 2017 Apr;48(2):109-115. doi: 10.1016/j.ocl.2016.12.001. Epub 2017 Jan 30.

PMID:
28336035
3.

Cost-Effective Mobile-Based Healthcare System for Managing Total Joint Arthroplasty Follow-Up.

Bitsaki M, Koutras G, Heep H, Koutras C.

Healthc Inform Res. 2017 Jan;23(1):67-73. doi: 10.4258/hir.2017.23.1.67. Epub 2017 Jan 31.

4.

Cost-utility of osteoarticular allograft versus endoprosthetic reconstruction for primary bone sarcoma of the knee: A markov analysis.

Wilson RJ, Sulieman LM, VanHouten JP, Halpern JL, Schwartz HS, Devin CJ, Holt GE.

J Surg Oncol. 2017 Mar;115(3):257-265. doi: 10.1002/jso.24525. Epub 2017 Jan 20.

PMID:
28105636
5.

Does Barbed Suture Lower Cost and Improve Outcome in Total Knee Arthroplasty? A Randomized Controlled Trial.

Chan VWK, Chan PK, Chiu KY, Yan CH, Ng FY.

J Arthroplasty. 2017 May;32(5):1474-1477. doi: 10.1016/j.arth.2016.12.015. Epub 2016 Dec 21.

PMID:
28089469
6.

Supervised neuromuscular exercise prior to hip and knee replacement: 12-month clinical effect and cost-utility analysis alongside a randomised controlled trial.

Fernandes L, Roos EM, Overgaard S, Villadsen A, S√łgaard R.

BMC Musculoskelet Disord. 2017 Jan 6;18(1):5. doi: 10.1186/s12891-016-1369-0.

7.

Using Patient-Reported Outcomes for Economic Evaluation: Getting the Timing Right.

Schilling C, Dowsey MM, Clarke PM, Choong PF.

Value Health. 2016 Dec;19(8):945-950. doi: 10.1016/j.jval.2016.05.014. Epub 2016 Jul 15.

PMID:
27987644
8.

Cost Analysis of Ceramic Heads in Primary Total Hip Arthroplasty.

Carnes KJ, Odum SM, Troyer JL, Fehring TK.

J Bone Joint Surg Am. 2016 Nov 2;98(21):1794-1800.

PMID:
27807111
9.

A cost-utility analysis of dabigatran, enoxaparin, and usual care for venous thromboprophylaxis after hip or knee replacement surgery in Thailand.

Kotirum S, Chongmelaxme B, Chaiyakunapruk N.

J Thromb Thrombolysis. 2017 Feb;43(2):252-262. doi: 10.1007/s11239-016-1433-5.

PMID:
27704332
10.

Establishing Age-Specific Cost-Effective Annual Revision Rates for Unicompartmental Knee Arthroplasty: A Meta-Analysis.

Chawla H, Ghomrawi HM, van der List JP, Eggman AA, Zuiderbaan HA, Pearle AD.

J Arthroplasty. 2017 Jan;32(1):326-335. doi: 10.1016/j.arth.2016.08.019. Epub 2016 Aug 28. Review.

PMID:
27692825
11.

Hyaluronic Acid Injections for Treatment of Advanced Osteoarthritis of the Knee: Utilization and Cost in a National Population Sample.

Weick JW, Bawa HS, Dirschl DR.

J Bone Joint Surg Am. 2016 Sep 7;98(17):1429-35. doi: 10.2106/JBJS.15.01358.

PMID:
27605686
12.
13.
14.

A nationwide analysis of socioeconomic outcomes after hip and knee replacement.

Kjellberg J, Kehlet H.

Dan Med J. 2016 Aug;63(8). pii: A5257.

PMID:
27477795
15.
16.

Cost effectiveness of meniscal allograft for torn discoid lateral meniscus in young women.

Ramme AJ, Strauss EJ, Jazrawi L, Gold HT.

Phys Sportsmed. 2016 Sep;44(3):278-82. doi: 10.1080/00913847.2016.1197762. Epub 2016 Jun 16.

PMID:
27270137
17.

Knee Joint Distraction Compared to Total Knee Arthroplasty for Treatment of End Stage Osteoarthritis: Simulating Long-Term Outcomes and Cost-Effectiveness.

van der Woude JA, Nair SC, Custers RJ, van Laar JM, Kuchuck NO, Lafeber FP, Welsing PM.

PLoS One. 2016 May 12;11(5):e0155524. doi: 10.1371/journal.pone.0155524. eCollection 2016.

18.

Clinical and financial benefits of intra-articular tranexamic acid in total knee arthroplasty.

Goyal N, Chen DB, Harris IA, Rowden N, Kirsh G, MacDessi SJ.

J Orthop Surg (Hong Kong). 2016 Apr;24(1):3-6.

19.

Cost-benefit evaluation of liposomal bupivacaine in the management of patients undergoing total knee arthroplasty.

Kirkness CS, Asche CV, Ren J, Kim M, Rainville EC.

Am J Health Syst Pharm. 2016 May 1;73(9):e247-54. doi: 10.2146/ajhp150332.

PMID:
27099332
20.

Cost-Effectiveness of Five Commonly Used Prosthesis Brands for Total Knee Replacement in the UK: A Study Using the NJR Dataset.

Pennington M, Grieve R, Black N, van der Meulen JH.

PLoS One. 2016 Mar 4;11(3):e0150074. doi: 10.1371/journal.pone.0150074. eCollection 2016.

Supplemental Content

Loading ...
Support Center